These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES). Hall MD, Daly HL, Zhang JZ, Zhang M, Alderden RA, Pursche D, Foran GJ, Hambley TW. Metallomics; 2012 Jun; 4(6):568-75. PubMed ID: 22569908 [Abstract] [Full Text] [Related]
3. Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs. Johnstone TC, Alexander SM, Wilson JJ, Lippard SJ. Dalton Trans; 2015 Jan 07; 44(1):119-29. PubMed ID: 25367395 [Abstract] [Full Text] [Related]
12. Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance. Papadia P, Micoli K, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N. Int J Mol Sci; 2020 Mar 27; 21(7):. PubMed ID: 32230896 [Abstract] [Full Text] [Related]
13. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions. Savino S, Marzano C, Gandin V, Hoeschele JD, Natile G, Margiotta N. Int J Mol Sci; 2018 Jul 14; 19(7):. PubMed ID: 30011897 [Abstract] [Full Text] [Related]
14. Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(IV) anticancer prodrugs. Yao H, Gunawan YF, Liu G, Tse MK, Zhu G. Dalton Trans; 2021 Oct 12; 50(39):13737-13747. PubMed ID: 34519297 [Abstract] [Full Text] [Related]
17. Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery. Yang J, Liu W, Sui M, Tang J, Shen Y. Biomaterials; 2011 Dec 12; 32(34):9136-43. PubMed ID: 21889206 [Abstract] [Full Text] [Related]
18. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts. Zhao Y, Woods JA, Farrer NJ, Robinson KS, Pracharova J, Kasparkova J, Novakova O, Li H, Salassa L, Pizarro AM, Clarkson GJ, Song L, Brabec V, Sadler PJ. Chemistry; 2013 Jul 15; 19(29):9578-91. PubMed ID: 23733242 [Abstract] [Full Text] [Related]
19. Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity. Aputen AD, Elias MG, Gilbert J, Sakoff JA, Gordon CP, Scott KF, Aldrich-Wright JR. Int J Mol Sci; 2024 Feb 11; 25(4):. PubMed ID: 38396859 [Abstract] [Full Text] [Related]
20. Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug-Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines. Barth MC, Häfner N, Runnebaum IB, Weigand W. Int J Mol Sci; 2023 Mar 16; 24(6):. PubMed ID: 36982792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]